↓ Skip to main content

Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo

Overview of attention for article published in Breast Cancer Research, April 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
patent
3 patents

Citations

dimensions_citation
178 Dimensions

Readers on

mendeley
175 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo
Published in
Breast Cancer Research, April 2011
DOI 10.1186/bcr2868
Pubmed ID
Authors

Mark Barok, Minna Tanner, Katri Köninki, Jorma Isola

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Japan 1 <1%
United States 1 <1%
France 1 <1%
Unknown 171 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 48 27%
Student > Ph. D. Student 31 18%
Student > Bachelor 21 12%
Student > Master 18 10%
Other 10 6%
Other 16 9%
Unknown 31 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 52 30%
Biochemistry, Genetics and Molecular Biology 32 18%
Medicine and Dentistry 17 10%
Pharmacology, Toxicology and Pharmaceutical Science 13 7%
Chemistry 10 6%
Other 14 8%
Unknown 37 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2021.
All research outputs
#2,256,596
of 26,017,215 outputs
Outputs from Breast Cancer Research
#214
of 2,086 outputs
Outputs of similar age
#9,570
of 124,246 outputs
Outputs of similar age from Breast Cancer Research
#2
of 24 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,086 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 124,246 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.